| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2007 ( Subtotal = $821,468 ) |
| | 2007 | 2007 | ACENTA DISCOVERY INC | 9030 SOUTH RITA ROAD ,STE 300 | TUCSON | AZ | 85747 | PIMA | USA | R43MH078433 | PIPERIDINE-BASED COMPOUNDS AS THERAPEUTICS FOR NARCOLEPSY-CATAPLEXY | 000 | 1 | NIH | 7/9/2007 | $250,000 |
| | 2007 | 2007 | ACENTA DISCOVERY INC | 9030 SOUTH RITA ROAD ,STE 300 | TUCSON | AZ | 85747 | PIMA | USA | R43NS062437 | DEVELOPMENT OF GSK-3 BETA INHIBITORS FOR THE TREATMENT OF PARKINSON'S DISEASE | 000 | 1 | NIH | 9/25/2007 | $282,568 |
| | 2007 | 2007 | ACENTA DISCOVERY INC | 9030 SOUTH RITA ROAD ,STE 300 | TUCSON | AZ | 85747 | PIMA | USA | R41DA023291 | NICOTINIC LIGANDS AS SMOKING CESSATION AGENTS | 000 | 1 | NIH | 5/1/2007 | $288,900 |
|
| Issue Date FY: 2006 ( Subtotal = $249,993 ) |
| | 2006 | 2006 | ACENTA DISCOVERY INC | 9030 SOUTH RITA ROAD ,STE 300 | TUCSON | AZ | 85747 | PIMA | USA | R41MH074193 | DEVELOPMENT OF NET-SELECTIVE PIPERIDINE-BASED PET LIGAND | 000 | 2 | NIH | 8/23/2006 | $49,932 |
| | 2006 | 2006 | ACENTA DISCOVERY INC | 9030 SOUTH RITA ROAD ,STE 300 | TUCSON | AZ | 85747 | PIMA | USA | R41MH074193 | DEVELOPMENT OF NET-SELECTIVE PIPERIDINE-BASED PET LIGAND | 000 | 2 | NIH | 8/23/2006 | $200,061 |
|
| Issue Date FY: 2005 ( Subtotal = $711,311 ) |
| | 2005 | 2005 | ACENTA DISCOVERY INC | | | | | | | R41CA102841 | AKT INHIBITORS TO TREAT EWING'S SARCOMA | 000 | 2 | NIH | 7/20/2005 | $298,310 |
| | 2005 | 2005 | ACENTA DISCOVERY INC | | | | | | | R41NS047013 | CASPASE INHIBITOR FOR NEUROPROTECTION | 000 | 2 | NIH | 3/25/2005 | $163,008 |
| | 2005 | 2005 | ACENTA DISCOVERY INC | | | | | | | R41MH074193 | DEVELOPMENT OF NET-SELECTIVE PIPERIDINE-BASED PET LIGAND | 000 | 1 | NIH | 9/30/2005 | $249,993 |
|
| Issue Date FY: 2004 ( Subtotal = $636,961 ) |
| | 2004 | 2004 | ACENTA DISCOVERY INC | | | | | | | R41MH070083 | NET - SELECTIVE LIGANDS FOR THE TREATMENT OF DEPRESSION | 000 | 2 | NIH | 7/20/2004 | $153,136 |
| | 2004 | 2004 | ACENTA DISCOVERY INC | | | | | | | R41NS047013 | CASPASE INHIBITOR FOR NEUROPROTECTION | 000 | 1 | NIH | 4/5/2004 | $185,515 |
| | 2004 | 2004 | ACENTA DISCOVERY INC | | | | | | | R41CA102841 | AKT INHIBITORS TO TREAT EWING'S SARCOMA | 000 | 1 | NIH | 8/2/2004 | $298,310 |
|
| Issue Date FY: 2003 ( Subtotal = $391,903 ) |
| | 2003 | 2003 | ACENTA DISCOVERY INC | 1600 NORTH OAK STREET | ARLINGTON | VA | 22209 | ARLINGTON | USA | R41MH070083 | NET - SELECTIVE LIGANDS FOR THE TREATMENT OF DEPRESSION | 000 | 1 | NIH | 9/30/2003 | $64,587 |
| | 2003 | 2003 | ACENTA DISCOVERY INC | 1600 NORTH OAK STREET | ARLINGTON | VA | 22209 | ARLINGTON | USA | R41MH070083 | NET - SELECTIVE LIGANDS FOR THE TREATMENT OF DEPRESSION | 000 | 1 | NIH | 9/30/2003 | $327,316 |
|
|
